A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension

Nitric oxide (NO) production by endothelial cell nitric oxide synthase (eNOS) in sinusoidal endothelial cells is reduced in the injured liver and leads to intrahepatic portal hypertension. We sought to understand the mechanism underlying defective eNOS function. Phosphorylation of the serine-threonine kinase Akt, which activates eNOS, was substantially reduced in sinusoidal endothelial cells from injured livers. Overexpression of Akt in vivo restored phosphorylation of Akt and production of NO and reduced portal pressure in portal hypertensive rats. We found that Akt physically interacts with G-protein-coupled receptor kinase-2 (GRK2), and that this interaction inhibits Akt activity. Furthermore, GRK2 expression increased in sinusoidal endothelial cells from portal hypertensive rats and knockdown of GRK2 restored Akt phosphorylation and NO production, and normalized portal pressure. Finally, after liver injury, GRK2-deficient mice developed less severe portal hypertension than control mice. Thus, an important mechanism underlying impaired activity of eNOS in injured sinusoidal endothelial cells is defective phosphorylation of Akt caused by overexpression of GRK2 after injury.

[1]  M. Birnbaum,et al.  Akt1 Regulates a JNK Scaffold during Excitotoxic Apoptosis , 2002, Neuron.

[2]  N. Dzimiri,et al.  Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases. , 2004, European journal of pharmacology.

[3]  D. Rockey,et al.  Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. , 1998, Gastroenterology.

[4]  Y. Hirata,et al.  Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. , 1993, The Journal of clinical investigation.

[5]  M. Quon,et al.  High Density Lipoprotein-induced Endothelial Nitric-oxide Synthase Activation Is Mediated by Akt and MAP Kinases* , 2003, The Journal of Biological Chemistry.

[6]  A. Lin,et al.  Subcellular Targeting and Agonist-induced Site-specific Phosphorylation of Endothelial Nitric-oxide Synthase* , 2002, The Journal of Biological Chemistry.

[7]  D. Rockey,et al.  Adenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[8]  W. Koch,et al.  Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts. , 2004, Circulation.

[9]  R. Penn,et al.  Analysis of the human G protein-coupled receptor kinase 2 (GRK2) gene promoter: regulation by signal transduction systems in aortic smooth muscle cells. , 2000, Circulation.

[10]  J. Kountouras,et al.  Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. , 1984, British journal of experimental pathology.

[11]  G. Garcı́a-Cardeña,et al.  Endothelial Nitric Oxide Synthase Is Regulated by Tyrosine Phosphorylation and Interacts with Caveolin-1* , 1996, The Journal of Biological Chemistry.

[12]  C. Carman,et al.  Selective Regulation of Gαq/11 by an RGS Domain in the G Protein-coupled Receptor Kinase, GRK2* , 1999, The Journal of Biological Chemistry.

[13]  W. Sessa,et al.  Direct Interaction between Endothelial Nitric-oxide Synthase and Dynamin-2 , 2001, The Journal of Biological Chemistry.

[14]  Brian A. Hemmings,et al.  Carboxyl-Terminal Modulator Protein (CTMP), a Negative Regulator of PKB/Akt and v-Akt at the Plasma Membrane , 2001, Science.

[15]  O. Feron,et al.  COUNTERBALANCING ALLOSTERIC MODULATORS OF ENDOTHELIAL NITRIC OXIDE SYNTHASE , 1997 .

[16]  D. Rockey,et al.  Endothelin-1 Activates Endothelial Cell Nitric-oxide Synthase via Heterotrimeric G-protein βγ Subunit Signaling to Protein Kinase B/Akt* , 2003, Journal of Biological Chemistry.

[17]  A. Malik,et al.  G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Penela,et al.  β‐arrestin‐ and c‐Src‐dependent degradation of G‐protein‐coupled receptor kinase 2 , 2001, The EMBO journal.

[19]  R. Lefkowitz,et al.  Keeping G Proteins at Bay: A Complex Between G Protein-Coupled Receptor Kinase 2 and Gßγ , 2003, Science.

[20]  M. Toruner,et al.  Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. , 1999, Gastroenterology.

[21]  W. Sessa,et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[22]  M. Goligorsky,et al.  Molecular and functional characterization of the non-isopeptide-selective ETB receptor in endothelial cells. Receptor coupling to nitric oxide synthase. , 1994, The Journal of biological chemistry.

[23]  M. Drazner,et al.  Monoclonal antibodies reveal receptor specificity among G-protein-coupled receptor kinases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Rockey,et al.  Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein betagamma subunit signaling to protein jinase B/Akt. , 2003, The Journal of biological chemistry.

[25]  B. Doble,et al.  GSK-3: tricks of the trade for a multi-tasking kinase , 2003, Journal of Cell Science.

[26]  R. Mahley,et al.  Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells , 1985, The Journal of cell biology.

[27]  M. Nishizawa,et al.  Up-regulation of IL-1 receptor through PI3K/Akt is essential for the induction of iNOS gene expression in hepatocytes. , 2004, Journal of hepatology.

[28]  W. Koch,et al.  Targeted &bgr;-Adrenergic Receptor Kinase (&bgr;ARK1) Inhibition by Gene Transfer in Failing Human Hearts , 2004 .

[29]  M. Caron,et al.  Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. York,et al.  Tyrosine 1101 of Tie2 Is the Major Site of Association of p85 and Is Required for Activation of Phosphatidylinositol 3-Kinase and Akt , 1998, Molecular and Cellular Biology.

[31]  Sumio Watanabe,et al.  Immunocytochemical Detection of Desmin in Fat‐Storing Cells (Ito Cells) , 1984, Hepatology.

[32]  Faculty Opinions recommendation of Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma. , 2003 .

[33]  J. Benovic,et al.  G-protein-coupled receptor kinase activity is increased in hypertension. , 1997, The Journal of clinical investigation.

[34]  D. Rockey,et al.  Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension. , 2000, The Journal of clinical investigation.

[35]  J. Liao,et al.  Inhibition of Rho-Kinase Leads to Rapid Activation of Phosphatidylinositol 3-Kinase/Protein Kinase Akt and Cardiovascular Protection , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[36]  D R Alessi,et al.  PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? , 2001, Journal of cell science.

[37]  Roger Fan,et al.  Dynamic activation of endothelial nitric oxide synthase by Hsp90 , 1998, Nature.

[38]  C. Ribas,et al.  Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. , 2003, Cellular signalling.